MRNA Jan 2025 125.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

22.40

0.00

(0.00%)

At close: 02:29PM EDT

Loading interactive chart…

Motley Fool
3 Things About Moderna That Smart Investors Know
Moderna (NASDAQ: MRNA) helped some investors make a fortune over the past few years. The stock has climbed more than 400% since March 2020 -- that's when the company's coronavirus vaccine program gained traction. Recently, though, investors have worried about Moderna's post-pandemic revenue, and that's weighed on share performance.
Zacks
Moderna (MRNA) Inks Genetic Medicines Deal With Generation Bio
Moderna (MRNA) collaborates with Generation Bio to develop non-viral genetic medicines. For this, it leverages the latter's closed-end DNA (ceDNA) and cell-targeted LNPs (ctLNP) technologies.
Simply Wall St.
With 65% institutional ownership, Moderna, Inc. (NASDAQ:MRNA) is a favorite amongst the big guns
Key Insights Given the large stake in the stock by institutions, Moderna's stock price might be vulnerable to their...